1. miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers
- Author
-
Khalil Arar, Christina Laurini, Michèle Sabbah, Laurent Vallar, Michèle Moes, Charles-Henri Lecellier, Evelyne Friederich, A. Le Bechec, Guillaume Vetter, Anne Saumet, Charles Theillet, Le Ster, Yves, Cytoskeleton and Cell Plasticity Lab, Université du Luxembourg (Uni.lu), Institut de recherche en cancérologie de Montpellier (IRCM - U896 Inserm - UM1), Université Montpellier 1 (UM1)-CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre de Recherche Publique- Santé, Centre de Recherche Saint-Antoine (UMRS893), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Sigma-Aldrich - Evry GENEPOLE, Sigma-Aldrich, Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), This work was supported by grants from the Fond National de la Recherche (FNR) du Luxembourg, (BIOSAN), the Fondation Luxembourgeoise Contre le Cancer, Human Frontier Science Program (RGP0058/2005), INSERM and CNRS, France. A. Saumet is a recipient of a fellowship from the Ministère de la Culture, de l'Enseignement Supérieur et de la Recherche, Luxembourg (BFR 08/046). M. Moes and A. Le Béchec are supported by AFR grants from the Fond National de la Recherche, Luxembourg., CRLCC Val d'Aurelle - Paul Lamarque-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Montpellier 1 (UM1), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Université du Luxembourg ( Uni.lu ), Institut de recherche en cancérologie de Montpellier ( IRCM ), Université Montpellier 1 ( UM1 ) -CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université de Montpellier ( UM ), Centre de Recherche Saint-Antoine ( CR Saint-Antoine ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Institut de Génétique Moléculaire de Montpellier ( IGMM ), and Université de Montpellier ( UM ) -Centre National de la Recherche Scientifique ( CNRS )
- Subjects
SNAI1 ,Cancer Research ,MESH : RNA, Messenger ,MESH : Transcription Factors ,MESH : Cell Dedifferentiation ,Gene Expression ,MESH : Breast Neoplasms ,Biochemistry, biophysics & molecular biology [F05] [Life sciences] ,Validation Studies as Topic ,MESH : RNA, Small Interfering ,medicine.disease_cause ,Bioinformatics ,MESH : Neoplasm Invasiveness ,[ SDV.CAN ] Life Sciences [q-bio]/Cancer ,Metastasis ,0302 clinical medicine ,MESH : Tumor Cells, Cultured ,MESH : Validation Studies as Topic ,EMT/miR-661/ SNAI1/StarD10/Nectin-1/breast cancer cell invasion ,MESH: RNA, Small Interfering ,Tumor Cells, Cultured ,MESH : Female ,RNA, Small Interfering ,Biochimie, biophysique & biologie moléculaire [F05] [Sciences du vivant] ,Oligonucleotide Array Sequence Analysis ,0303 health sciences ,EMT ,MESH: Transcription Factors ,MESH: Gene Expression Regulation, Neoplastic ,MESH : Epithelial Cells ,Gene Expression Regulation, Neoplastic ,MESH : Oligonucleotide Array Sequence Analysis ,MESH: Epithelial Cells ,030220 oncology & carcinogenesis ,MESH: Cell Adhesion Molecules ,Female ,Breast disease ,StarD10 ,Nectin-1 ,MESH: Gene Expression ,MESH : Gene Expression Regulation, Neoplastic ,Nectins ,Breast Neoplasms ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Biology ,MESH: Phosphoproteins ,MESH : Cell Adhesion Molecules ,MESH: Gene Expression Profiling ,03 medical and health sciences ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,microRNA ,Genetics ,medicine ,Humans ,Gene silencing ,Neoplasm Invasiveness ,RNA, Messenger ,MESH: Tumor Cells, Cultured ,Epithelial–mesenchymal transition ,Molecular Biology ,MESH: RNA, Messenger ,030304 developmental biology ,breast cancer cell invasion ,MESH: Validation Studies as Topic ,MESH: Humans ,MESH : Gene Expression Profiling ,Gene Expression Profiling ,MESH : Humans ,Cancer ,Epithelial Cells ,Mesenchymal Stem Cells ,MESH: Neoplasm Invasiveness ,Cell Dedifferentiation ,Phosphoproteins ,medicine.disease ,MESH: Cell Dedifferentiation ,miR-661 ,MESH : Gene Expression ,MESH : MicroRNAs ,MicroRNAs ,Retraction Note ,MESH: Mesenchymal Stem Cells ,MESH: Oligonucleotide Array Sequence Analysis ,Cancer research ,Snail Family Transcription Factors ,MESH : Phosphoproteins ,MESH : Mesenchymal Stem Cells ,Carcinogenesis ,Cell Adhesion Molecules ,MESH: MicroRNAs ,MESH: Female ,MESH: Breast Neoplasms ,Transcription Factors - Abstract
4; International audience; Epithelial to mesenchymal transition (EMT) is a key step toward metastasis. MCF7 breast cancer cells conditionally expressing the EMT master regulator SNAI1 were used to identify early expressed microRNAs (miRNAs) and their targets that may contribute to the EMT process. Potential targets of miRNAs were identified by matching lists of in silico predicted targets and of inversely expressed mRNAs. MiRNAs were ranked based on the number of predicted hits, highlighting miR-661, a miRNA with so far no reported role in EMT. MiR-661 was found required for efficient invasion of breast cancer cells by destabilizing two of its predicted mRNA targets, the cell-cell adhesion protein Nectin-1 and the lipid transferase StarD10, resulting, in turn, in the downregulation of epithelial markers. Reexpression of Nectin-1 or StarD10 lacking the 3'-untranslated region counteracted SNAI1-induced invasion. Importantly, analysis of public transcriptomic data from a cohort of 295 well-characterized breast tumor specimen revealed that expression of StarD10 is highly associated with markers of luminal subtypes whereas its loss negatively correlated with the EMT-related, basal-like subtype. Collectively, our non-a priori approach revealed a nonpredicted link between SNAI1-triggered EMT and the down-regulation of Nectin-1 and StarD10 through the up-regulation of miR-661, which may contribute to the invasion of breast cancer cells and poor disease outcome.
- Published
- 2010
- Full Text
- View/download PDF